骨質疏鬆症治療市場：依藥物類型、給藥途徑、通路及地區分類

Osteoporosis Treatment Market, By Drug Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2026年骨質疏鬆症治療市值為162.9億美元，預計2033年將達到223.1億美元。預計從2026年到2033年，該市場將以4.6%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	162.9億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	4.60%	2033年市場規模預測：	223.1億美元

骨質疏鬆症是一種以骨量減少和骨組織結構劣化為特徵的疾病，會導致骨骼脆弱，增加骨折風險。這種疾病是全球主要的公共衛生問題，尤其是在老年人群中。預期壽命延長、久坐的生活方式和營養不良等因素顯著加劇了已開發國家和開發中國家骨質疏鬆症的盛行率。根據 Frontiers 發布的數據顯示，全球有超過 2 億人患有骨質疏鬆症。目前治療方法根治性，因此終身藥物治療在治療和預防骨折方面起著至關重要的作用。為了滿足這一未被滿足的需求，全球骨質疏鬆症治療市場在過去幾十年中穩步成長。

市場動態

老年人口的不斷成長，尤其是骨質疏鬆症高風險族群，預計將推動全球對骨質疏鬆症治療藥物的需求。根據聯合國預測，到2050年，65歲及以上人口數量將增加一倍以上。人們對骨質疏鬆症篩檢和管理的認知不斷提高，新產品的上市以及高風險患者診斷率的提高，都進一步促進了市場成長。然而，專利到期以及消費者對學名藥的偏好，仍然限制市場成長。同時，新興市場醫療保健覆蓋範圍的擴大，也帶來了巨大的發展機會。

本次調查的主要特點

本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球骨質疏鬆症治療市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本調查涵蓋的主要公司包括梯瓦製藥工業有限公司、第一三共株式會社、安進、瑞迪博士實驗室、Beatrice、Ligand Pharmaceuticals、禮來公司、旭化成株式會社、羅氏有限公司、FRX Pharmaceuticals、諾華、默克公司、葛蘭素史克、輝瑞、Enzen Biosciences 和 Aexpot。
本報告中的見解將使各公司的行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球骨質疏鬆症治療市場包括該行業的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過各種用於分析全球骨質疏鬆症治療市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Teva Pharmaceutical Industries Ltd.
- DAIICHI SANKYO COMPANY, LIMITED
- Amgen Inc.
- Dr. Reddy's Laboratories Ltd.
- Viatris Inc.
- Ligand Pharmaceuticals Incorporated
- Eli Lilly and Company
- Asahi Kasei Corporation
- F. Hoffmann-La Roche Ltd.
- EffRx Pharmaceuticals SA
- Novartis AG
- Merck & Co., Inc.
- GSK plc.
- Pfizer Inc.
- Enzene Biosciences
- Apotex Inc.

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI1096

Osteoporosis Treatment Market is estimated to be valued at USD 16.29 Bn in 2026 and is expected to reach USD 22.31 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 16.29 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.60%	2033 Value Projection:	USD 22.31 Bn

Osteoporosis is a condition characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an increased risk of fractures. The disease has become a major global healthcare concern, especially among the elderly population. Factors such as increasing life expectancy, sedentary lifestyles, and improper nutrition have contributed significantly to rising prevalence of osteoporosis across both developed and developing nations. According to data published by Frontiers, over 200 million people worldwide suffer from osteoporosis. With no curative treatment currently available, lifelong management through pharmacotherapy plays a crucial role in treatment and prevention of fractures. Global osteoporosis treatment market has witnessed steady growth over the past couple of decades to meet this unmet need.

Market Dynamics

Growing geriatric population who are at high risk of osteoporosis is expected to boost demand for osteoporosis treatment drugs globally. According to the United Nations, the population aged 65 years and above is expected to more than double by 2050. Rising awareness about osteoporosis screening and management, new product launches, and increasing at-risk patient diagnosis are further propelling the market growth. However, patent expiries of blockbuster drugs and preference for generic drugs continue to restrain the market growth. Meanwhile, significant opportunities lie in emerging economies due to growing accessibility of healthcare.

Key Features of the Study

It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global osteoporosis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this includes Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY, LIMITED, Amgen Inc., Dr. Reddy's Laboratories Ltd., Viatris Inc., Ligand Pharmaceuticals Incorporated, Eli Lilly and Company, Asahi Kasei Corporation, F. Hoffmann-La Roche Ltd, EffRx Pharmaceuticals SA, Novartis AG, Merck & Co., Inc., GSK plc., Pfizer Inc., Enzene Biosciences, Apotex Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global osteoporosis treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global osteoporosis treatment market.

Market Segmentation

Drug Type Insights (Revenue, USD Bn, 2026 - 2033)
Bisphosphonates
Calcitonin, Hormone Therapy
Selective Estrogen Receptor Modulators (SERMs)
Parathyroid Hormone-Related Protein (PTHrP) Analog
Others
Route Of Administration Insights (Revenue, USD Bn, 2026 - 2033)
Oral
Injectable
Others
Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2026 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Teva Pharmaceutical Industries Ltd.
DAIICHI SANKYO COMPANY, LIMITED
Amgen Inc.
Dr. Reddy's Laboratories Ltd.
Viatris Inc.
Ligand Pharmaceuticals Incorporated
Eli Lilly and Company
Asahi Kasei Corporation
F. Hoffmann-La Roche Ltd
EffRx Pharmaceuticals SA
Novartis AG
Merck & Co., Inc.
GSK plc.
Pfizer Inc.
Enzene Biosciences
Apotex Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Osteoporosis Treatment Market, By Drug Type, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Bisphosphonates
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Calcitonin, Hormone Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Selective Estrogen Receptor Modulators (SERMs)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Parathyroid Hormone-Related Protein (PTHrP) Analog
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Osteoporosis Treatment Market, By Route of Administration, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Injectable
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Osteoporosis Treatment Market, By Distribution Channel, 2021 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Osteoporosis Treatment Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- DAIICHI SANKYO COMPANY, LIMITED
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dr. Reddy's Laboratories Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Viatris Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ligand Pharmaceuticals Incorporated
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Asahi Kasei Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- F. Hoffmann-La Roche Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- EffRx Pharmaceuticals SA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GSK plc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Enzene Biosciences
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Apotex Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies